• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Dental Science Updates
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 6 (2025)
Volume Volume 5 (2024)
Volume Volume 4 (2023)
Volume Volume 3 (2022)
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2021)
Volume Volume 1 (2020)
Mohamed, B., elsafy, R., Abo Elezz, A., Fahmy, O. (2022). Assessment of Biological Properties of Zirconia Reinforced Glass Ionomer versus Glass Ionomer with Glass Hybrid Technology in Class II Cavities. Randomized Controlled Clinical Trial. Dental Science Updates, 3(2), 191-198. doi: 10.21608/dsu.2022.113472.1095
Basma Hosny Mohamed; rehab khalil elsafy; Ahmed Fawzy Abo Elezz; Ola Mohamed Fahmy. "Assessment of Biological Properties of Zirconia Reinforced Glass Ionomer versus Glass Ionomer with Glass Hybrid Technology in Class II Cavities. Randomized Controlled Clinical Trial". Dental Science Updates, 3, 2, 2022, 191-198. doi: 10.21608/dsu.2022.113472.1095
Mohamed, B., elsafy, R., Abo Elezz, A., Fahmy, O. (2022). 'Assessment of Biological Properties of Zirconia Reinforced Glass Ionomer versus Glass Ionomer with Glass Hybrid Technology in Class II Cavities. Randomized Controlled Clinical Trial', Dental Science Updates, 3(2), pp. 191-198. doi: 10.21608/dsu.2022.113472.1095
Mohamed, B., elsafy, R., Abo Elezz, A., Fahmy, O. Assessment of Biological Properties of Zirconia Reinforced Glass Ionomer versus Glass Ionomer with Glass Hybrid Technology in Class II Cavities. Randomized Controlled Clinical Trial. Dental Science Updates, 2022; 3(2): 191-198. doi: 10.21608/dsu.2022.113472.1095

Assessment of Biological Properties of Zirconia Reinforced Glass Ionomer versus Glass Ionomer with Glass Hybrid Technology in Class II Cavities. Randomized Controlled Clinical Trial

Article 9, Volume 3, Issue 2, September 2022, Page 191-198  XML PDF (954.68 K)
Document Type: Original Article
DOI: 10.21608/dsu.2022.113472.1095
View on SCiNiTO View on SCiNiTO
Authors
Basma Hosny Mohamed email orcid 1; rehab khalil elsafy1; Ahmed Fawzy Abo Elezz2; Ola Mohamed Fahmy3
1Operative Dentistry Department, Faculty of Dentistry, Suez Canal University, Ismailia, Egypt
2Faculty of Dentistry, Suez Canal University, Ismailia, 41522, Egypt
3Operative Dentistry Department, Faculty of Oral and Dental Medicine, Misr International University, Cairo, Egypt
Abstract
Introduction: Glass ionomer cement (GIC) has numerous advantages over other restorative materials. In particular, self-adhesion to tooth structure in addition to its fluoride release that makes it suitable for treatment of majority of high caries risk cases. However, clinical usage of GIC is still limited due to their sensitivity to initial desiccation, low resistance to abrasion and low esthetic properties explaining why these materials are not widely used for permanent fillings. Materials and Methods: Class II occlusal slot cavities were prepared in the first permanent molar of sixty patients and restored randomly by two restorations, either; EQUIA® Forte Fil (Glass ionomer with glass hybrid technology) or Zirconomer® Improved (Zirconia-reinforced glass ionomer). Restorations were evaluated according to FDI criteria in terms of biological properties at baseline, after six months and one year. Results: Chi-square and Mann-Whitney tests revealed that there was no statistically significant difference between both materials with 100% success in all restorations in both groups at the base line. At six months follow up time, 92% of the EQUIA®Forte Fil group and 68% of the Zirconomer® Improved group were clinically successful. Meanwhile, at 12 months follow up time, 88% of the EQUIA®Forte Fil group and 48% of the Zirconomer® Improved group were clinically successful with significant difference between them at both six and 12 months. Conclusions: Glass ionomer with glass hybrid technology exhibited better clinical performance in terms of biological properties than zirconia-reinforced glass ionomer in class II slot cavities after six months and one year
Keywords
Biological properties; FDI criteria; Glass ionomer; Glass hybrid technology; Zirconia reinforced
Main Subjects
Conservative dentistry
Statistics
Article View: 398
PDF Download: 513
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.